Chang Jin Wang
Gründer bei FRONTIER BIOTECHNOLOGIES INC.
Vermögen: 19 Mio $ am 30.04.2024
Aktive Positionen von Chang Jin Wang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| FRONTIER BIOTECHNOLOGIES INC. | Direktor/Vorstandsmitglied | 15.01.2013 | - |
| Vorstandsvorsitzender | 15.01.2013 | - | |
| Gründer | 15.01.2013 | - |
Karriereverlauf von Chang Jin Wang
Ehemalige bekannte Positionen von Chang Jin Wang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Abmaxis, Inc.
 Abmaxis, Inc. Pharmaceuticals: MajorHealth Technology Abmaxis Inc. develops pharmaceutical drugs. The company discovers and optimizes monoclonal antibody (mAb) products for human therapeutics and diagnostics. It has developed antibody engineering technology platform, Abmaxis in-silico Immunization (AISIM TM), which they are used for building an internal product pipeline and collaboration with global biotech and pharmaceutical partners. The company was founded in 2000 and is located in Santa Clara, CA. | Corporate Officer/Principal | 01.03.2005 | 01.07.2006 |
TaiGen Biotechnology Co., Ltd.
 TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Corporate Officer/Principal | 01.04.2002 | 01.05.2004 |
| VIVUS, INC. | Corporate Officer/Principal | 01.11.2006 | - |
Ausbildung von Chang Jin Wang
| University of Kentucky | Doctorate Degree |
| West China University of Medical Sciences | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| China | 3 |
| Taiwan | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FRONTIER BIOTECHNOLOGIES INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
Abmaxis, Inc.
Abmaxis, Inc. Pharmaceuticals: MajorHealth Technology Abmaxis Inc. develops pharmaceutical drugs. The company discovers and optimizes monoclonal antibody (mAb) products for human therapeutics and diagnostics. It has developed antibody engineering technology platform, Abmaxis in-silico Immunization (AISIM TM), which they are used for building an internal product pipeline and collaboration with global biotech and pharmaceutical partners. The company was founded in 2000 and is located in Santa Clara, CA. | Health Technology |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Health Technology |
- Börse
- Insiders
- Chang Jin Wang
- Erfahrung
